Log In
BCIQ
Print this Print this
 

Nascobal, cyanocobalamin

Also known as: Nascobol Nasal Spray

  Manage Alerts
Collapse Summary General Information
Company QOL Medical LLC
DescriptionIntranasal cyancobalamin spray
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationVitamin B-12 deficiency
Indication DetailsMaintain levels of vitamin B12 in HIV, AIDS, multiple sclerosis (MS) patients; Treat vitamin B-12 deficiency
Regulatory Designation
PartnerEndo International plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$54.5M

$54.5M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/06/2009

$54.5M

$54.5M

0

Get a free BioCentury trial today